跳至主要内容
临床试验/EUCTR2007-005232-81-NL
EUCTR2007-005232-81-NL进行中(未招募)不适用

Wet-wrap treatment in children with atopic eczema using the wet-wrap method with diluted corticosteroids versus emollients - Wet-wrap study

Havenziekenhuis/ErasmusMC0 个研究点目标入组 50 人开始时间: 2008年1月8日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Age 6 months- 6 years at inclusion
  • Diagnosis of atopic eczema with an objective SCORAD = 40
  • Parent/legal guardian willing to comply with the protocol
  • Written, dated consent for subject to participate
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Known pre-existing, serious underlying disease
  • (secondary) infected eczema:
  • oIn case of overt impetiginisation, wet wrapping should be delayed until 48-72 hours after commencing antibiotics and confirmation of appropriate treatment by skin swab results.
  • oEczema herpeticum is an absolute contraindication for the use of wet dressings.
  • Signs and symptoms of systemic infection (such as fever, defined as a temperature equivalent to a rectal temperature greater than 38.3ºC).
  • Problems in the hypothalamus-pituitary-adrenal axis (HPA)
  • Systemic corticosteroid therapy
  • Severe growth retardation

研究者

发起方
Havenziekenhuis/ErasmusMC

相似试验

Wet-wrap treatment in children with atopic eczema... | 临床试验